rs368248592
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PM1PM2PM5PP3_StrongPP5_Very_Strong
The NM_012144.4(DNAI1):c.1612G>A(p.Ala538Thr) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000911 in 1,613,946 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. A538S) has been classified as Uncertain significance.
Frequency
Consequence
NM_012144.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
DNAI1 | NM_012144.4 | c.1612G>A | p.Ala538Thr | missense_variant | 17/20 | ENST00000242317.9 | |
DNAI1 | NM_001281428.2 | c.1624G>A | p.Ala542Thr | missense_variant | 17/20 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
DNAI1 | ENST00000242317.9 | c.1612G>A | p.Ala538Thr | missense_variant | 17/20 | 1 | NM_012144.4 |
Frequencies
GnomAD3 genomes AF: 0.0000723 AC: 11AN: 152068Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000756 AC: 19AN: 251310Hom.: 0 AF XY: 0.000103 AC XY: 14AN XY: 135832
GnomAD4 exome AF: 0.0000930 AC: 136AN: 1461878Hom.: 0 Cov.: 32 AF XY: 0.0000908 AC XY: 66AN XY: 727240
GnomAD4 genome AF: 0.0000723 AC: 11AN: 152068Hom.: 0 Cov.: 32 AF XY: 0.0000538 AC XY: 4AN XY: 74288
ClinVar
Submissions by phenotype
Primary ciliary dyskinesia Pathogenic:4
Pathogenic, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 10, 2015 | The p.A538T pathogenic mutation (also known as c.1612G>A), located in coding exon 17 of the DNAI1 gene, results from a G to A substitution at nucleotide position 1612. The alanine at codon 538 is replaced by threonine, an amino acid with some similar properties. This alteration was first reported in two unrelated individuals with symptoms of PCD with a second pathogenic alteration (confirmed in trans in one patient); both patients had outer dynein arm defects identified by ultrastructual analysis (Zariwala MA et al. Am J Respir Crit Care Med. 2006;174(8):858-66). In addition, this alteration was identified in the homozygous state in three families and in conjunction with another pathogenic mutation in an additional two patients, all who had symptoms of PCD and dynein arm defects; authors suggest this alteration may be a Polish founder mutation (Zitkiewicz E et al. Respir Res. 2010;11:174). Based on the supporting evidence, p.A538T is interpreted as a disease-causing mutation. - |
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 14, 2023 | This sequence change replaces alanine, which is neutral and non-polar, with threonine, which is neutral and polar, at codon 538 of the DNAI1 protein (p.Ala538Thr). This variant is present in population databases (rs368248592, gnomAD 0.01%). This missense change has been observed in individual(s) with primary ciliary dyskinesia (PMID: 16858015, 21143860). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. ClinVar contains an entry for this variant (Variation ID: 583106). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) has been performed at Invitae for this missense variant, however the output from this modeling did not meet the statistical confidence thresholds required to predict the impact of this variant on DNAI1 protein function. For these reasons, this variant has been classified as Pathogenic. - |
Likely pathogenic, no assertion criteria provided | literature only | Yale Center for Mendelian Genomics, Yale University | Aug 01, 2018 | - - |
Pathogenic, no assertion criteria provided | clinical testing | Natera, Inc. | Sep 16, 2020 | - - |
See cases Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Institute of Human Genetics, University Hospital Muenster | Jul 07, 2022 | ACMG categories: PS4,PM1,PM2,PM3,PP1,PP3,PP5 - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at